Abstract
In order to find efficient new antitumor drugs, a series of novel pyrimidine derivatives containing urea moiety were designed and synthesized, and the antitumor activity of four human tumor cells was evaluated by MTT analysis. The results showed that most of the target compounds exhibited moderate antitumor activity. In particular, the IC50 (concentration required to achieve 50% inhibition of the tumor cell proliferation) value of compound 2-((4-(4-ethylphenoxy)-6-(trifluoromethyl)pyrimidin-2-yl)thio)-N-((4-ethylphenyl)carba-moyl)acetamide for MGC-803 (human gastric carcinoma cell line) was 2.51 ± 0.17 µmol L–1, the anti-proliferative activity was significantly better than the positive control drug 5-fluorouracil. Molecular docking revealed that this compound can bind well to the active site of epidermal growth factor receptor (EGFR), and it may become a potential antitumor drug.
Similar content being viewed by others
REFERENCES
Perupogu, N., Kumar, D.R., and Ramachandran, D., Chem. Data Collect., 2020, vol. 27. https://doi.org/10.1016/j.cdc.2020.100363
Ye, T., Han, Y., Wang, R., Yan, P., Chen, S., Hou, Y., and Zhao, Y., Bioorg. Chem., 2020, vol. 99, p. 103796. https://doi.org/10.1016/j.bioorg.2020.103796
Romu, A.A., Lei, Z., Zhou, B., Chen, Z.S., and Korlipara, V., Bioorg. Med. Chem. Lett., 2017, vol. 27, pp. 4832–4837. https://doi.org/10.1016/j.bmcl.2017.09.048
Zhou, W., Ercan, D., Chen, L., Yun, C.H., Li, D., Capelletti, M., Cortot, A.B., Chirieac, L., Iacob, R.E., Padera, R., Engen, J.R., Wong, K.K., Eck, M.J., Gray, N.S., and Janne, P.A., Nature, 2009, vol. 462, pp. 1070–1074. https://doi.org/10.1038/nature08622
Walter, A.O., Sjin, R.T., Haringsma, H.J., Ohashi, K., Sun, J., Lee, K., Dubrovskiy, A., Labenski, M., Zhu, Z., Wang, Z., Sheets, M., St Martin, T., Karp, R., van Kalken, D., Chaturvedi, P., Niu, D., Nacht, M., Petter, R.C., Westlin, W., Lin, K., Jaw-Tsai, S., Raponi, M., Van Dyke, T., Etter, J., Weaver, Z., Pao, W., Singh, J., Simmons, A.D., Harding, T.C., and Allen, A., Cancer Discov., 2013, vol. 3, pp. 1404–1415. https://doi.org/10.1158/2159-8290.CD-13-0314
Cross, D.A., Ashton, S.E., Ghiorghiu, S., Eberlein, C., Nebhan, C.A., Spitzler, P.J., Orme, J.P., Finlay, M.R., Ward, R.A., Mellor, M.J., Hughes, G., Rahi, A., Jacobs, V.N., Red Brewer, M., Ichihara, E., Sun, J., Jin, H., Ballard, P., Al-Kadhimi, K., Rowlinson, R., Klinowska, T., Richmond, G.H., Cantarini, M., Kim, D.W., Ranson, M.R., and Pao, W., Cancer Discov., 2014, vol. 4, pp. 1046–1061. https://doi.org/10.1158/2159-8290.CD-14-0337
Finlay, M.R., Anderton, M., Ashton, S., Ballard, P., Bethel, P.A., Box, M.R., Bradbury, R.H., Brown, S.J., Butterworth, S., Campbell, A., Chorley, C., Colclough, N., Cross, D.A., Currie, G.S., Grist, M., Hassall, L., Hill, G.B., James, D., James, M., Kemmitt, P., Klinowska, T., Lamont, G., Lamont, S.G., Martin, N., McFarland, H.L., Mellor, M.J., Orme, J.P., Perkins, D., Perkins, P., Richmond, G., Smith, P., Ward, R.A., Waring, M.J., Whittaker, D., Wells, S., and Wrigley, G.L., J. Med. Chem., 2014, vol. 57, pp. 8249–8267. https://doi.org/10.1021/jm500973a
Rekunge, D.S., Khatri, C.K., and Chaturbhuj, G.U., Tetrahedron Lett., 2017, vol. 58, pp. 4304–4307. https://doi.org/10.1016/j.tetlet.2017.10.001
Tokala, R., Bale, S., Janrao, I.P., Vennela, A., Kumar, N.P., Senwar, K.R., Godugu, C., and Shankaraiah, N., Bioorg. Med. Chem. Lett., 2018, vol. 28, pp. 1919–1924. https://doi.org/10.1016/j.bmcl.2018.03.074
Saurat, T., Buron, F., Rodrigues, N., de Tauzia, M.L., Colliandre, L., Bourg, S., Bonnet, P., Guillaumet, G., Akssira, M., Corlu, A., Guillouzo, C., Berthier, P., Rio, P., Jourdan, M.L., Benedetti, H., and Routier, S., J. Med. Chem., 2014, vol. 57, pp. 613–631. https://doi.org/10.1021/jm401138v
Li, J., Huang, L., Yan, J., Zhou, F., Liu, C., and Yan, Y., J. Med. Coll. PLA, 2011, vol. 26, pp. 324–334. https://doi.org/10.1016/s1000-1948(12)60028-8
Kane, R.C., Farrell, A.T., Saber, H., Tang, S., Williams, G., Jee, J.M., Liang, C., Booth, B., Chidambaram, N., Morse, D., Sridhara, R., Garvey, P., Justice, R., and Pazdur, R., Clin. Cancer Res., 2006, vol. 12, pp. 7271–7278. https://doi.org/10.1158/1078-0432.CCR-06-1249
Eicher, C., Dewerth, A., Kirchner, B., Warmann, S.W., Fuchs, J., and Armeanu-Ebinger, S., Liver Int., 2012, vol. 32, pp. 574–581. https://doi.org/10.1111/j.1478-3231.2011.02729.x
Eicher, C., Dewerth, A., Thomale, J., Ellerkamp, V., Hildenbrand, S., Warmann, S.W., Fuchs, J., and Armeanu-Ebinger, S., Br. J. Cancer, 2013, vol. 108, pp. 334–341. https://doi.org/10.1038/bjc.2012.539
Haddad, Y., Remes, M., Adam, V., and Heger, Z., Drug Discov. Today, 2021, vol. 26, pp. 289–295. https://doi.org/10.1016/j.drudis.2020.10.007
Cherukupalli, S., Chandrasekaran, B., Aleti, R.R., Sayyad, N., Hampannavar, G.A., Merugu, S.R., Rachamalla, H.R., Banerjee, R., and Karpoormath, R., J. Mol. Struct., 2019, vol. 1176, pp. 538–551. https://doi.org/10.1016/j.molstruc.2018.08.104
Abdel-Mohsen, H.T., Conrad, J., Harms, K., Nohr, D., and Beifuss, U., RSC Adv., 2017, vol. 7, pp. 17427–17441. https://doi.org/10.1039/c6ra28102h
Funding
Project supported by the National Natural Science Foundation of China (no. 81773562) and this work was supported by National Key Research Program of Proteins (no. 2018YFE0195100) and Openning fund from State Key Laboratory of Esophageal Cancer Prevention & Treatment (no. K2020000X).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
The work has no studies involving humans or animals as subjects of the study.
Conflict of Interests
Authors declare they have no conflicts of interest.
Supplementary Information
Rights and permissions
About this article
Cite this article
Liu Limin, Zhengjie, W., Xiujuan, L. et al. Design, Synthesis, and Antitumor Activity Evaluation of Trifluoromethyl-Substituted Pyrimidine Derivatives Containing Urea Moiety. Russ J Bioorg Chem 47, 1301–1311 (2021). https://doi.org/10.1134/S1068162021060157
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162021060157